Founded in 1987, Clonit srl was one of the first Italian companies operating in the field of biotechnology.
Since from the beginning the company has worked to develope innovative and reliable analytical methods in the field of In Vitro diagnostics using molecular biology techinques.
Nuovo fastGEN TP53 Cancer kit
Il Gruppo Clonit, distributore esclusivo per l’Italia di BioVendor R&D®, annuncia il lancio del nuovo kit fastGEN TP53. Mutazioni somatiche del gene TP53 si riscontrano...
Read news detailsMEDICA 2023
MEDICA - Leading International Trade Fair 2023 is very close. Clonit will exhibit at Hall 3 – C60. Come and join our team, we will introduce you to our large panel of molecular diagnostic...
Read news detailsComunicazione variazione sede operativa Clonit
Desideriamo comunicare alla gentile clientela e ai fornitori che, a far data dal 28 Novembre 2022, la nostra Società ha trasferito la propria sede operativa da Via Lombardia 6, 27010 Siziano...
Read news details